Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• TD Cowen analyst Robert Moskow upgraded the rating for The Clorox Company (NYSE:CLX) from Sell to Hold and raises the price target from $155 to $170. Clorox shares closed at $162.42 on Tuesday. See how other analysts view this stock.
• Barclays analyst Trevor Young upgraded Revolve Group, Inc. (NYSE:RVLV) from Underweight to Equal-Weight and raised the price target from $17 to $25. Revolve shares closed at $26.02 on Tuesday. See how other analysts view this stock.
• Leerink Partners analyst Rick Bienkowski upgraded the rating for Beam Therapeutics Inc. (NASDAQ:BEAM) from Market Perform to Outperform and increased the price target from $27 to $39. Beam Therapeutics shares closed at $23.93 on Tuesday. See how other analysts view this stock.
• Deutsche Bank analyst David Begleiter upgraded Celanese Corporation (NYSE:CE) from Hold to Buy and lowered the price target from $135 to $110. Celanese shares closed at $91.00 on Tuesday. See how other analysts view this stock.

Considering buying CLX stock? Here's what analysts think:

Read More:

• Jim Cramer Says He Can't Recommend This Major Automaker, Ceva Is 'Way Too High'